Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CNCE | TRML | HROW | ||
| Company | Concert Pharmaceutic | Tourmaline Bio Inc | Harrow Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.38 | 15.92 | 10.57 | ||
| High | 8.55 | 16.40 | 10.74 | ||
| Low | 8.35 | 15.30 | 10.44 | ||
| Last | 8.37 | 15.50 | 10.62 | ||
| Change | +0.01 | -0.18 | +0.09 | ||
| % Change | +0.12% | -1.15% | +0.85% | ||
| Volume | 10,733,200 | 233,700 | 360,800 | ||
| 20-Day Average Volume | 2,014,915 | 445,305 | 420,035 | ||
| Previous Close | 8.36 | 15.68 | 10.53 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.37 | 18.61 | 11.87 | ||
| 20-Day Raw Stochastic | 25.00% | 8.88% | 20.05% | ||
| 20-Day Relative Strength | 67.20% | 30.21% | 43.45% | ||
| Weighted Alpha | +122.30 | +29.59 | -48.34 | ||
| Today's Opinion | 96% Buy | 40% Sell | 40% Sell | ||
| Previous Opinion | 88% Buy | 40% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 8% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.12% since 02/24/23 | unch since 04/22/24 | +0.19% since 04/22/24 | ||
| Low | 8.35 on 03/02/23 | 14.70 on 04/25/24 | 9.86 on 04/25/24 | ||
| High | 8.55 on 03/03/23 | 16.40 on 04/29/24 | 10.87 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | unch since 02/03/23 | -32.31% since 03/28/24 | -19.73% since 03/28/24 | ||
| Low | 8.31 on 02/10/23 | 14.70 on 04/25/24 | 9.86 on 04/25/24 | ||
| High | 8.55 on 03/03/23 | 23.71 on 04/08/24 | 13.72 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | +72.22% since 12/02/22 | -57.56% since 01/29/24 | +6.20% since 01/29/24 | ||
| Low | 4.20 on 12/07/22 | 14.70 on 04/25/24 | 9.13 on 02/05/24 | ||
| High | 8.55 on 03/03/23 | 48.31 on 03/13/24 | 13.72 on 04/01/24 | ||
| 6-Month | |||||
| %Chg | +20.43% since 09/02/22 | +10.71% since 10/27/23 | -22.54% since 10/27/23 | ||
| Low | 4.20 on 12/07/22 | 13.81 on 11/07/23 | 7.60 on 11/14/23 | ||
| High | 8.55 on 03/03/23 | 48.31 on 03/13/24 | 14.58 on 10/31/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 401,241 | 402,145 | 372,372 | ||
| Shares Outstanding, K | 47,938 | 25,647 | 35,363 | ||
| Annual Sales | 32,580,000 | 0 | 130,190,000 | ||
| Annual Net Income | -80,050,000 | -42,120,000 | -24,410,000 | ||
| Last Quarter Sales | 10,000 | 0 | 36,350,000 | ||
| Last Quarter Net Income | -28,900,000 | 2,130,000 | -9,150,000 | ||
| 60-Month Beta | 0.52 | 2.33 | 0.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.58 on 11/07/22 | -0.81 on 03/19/24 | -0.27 on 03/19/24 | ||
| Latest Earnings Date | 03/09/23 | 05/20/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||